Mercè Boada, MD, PhD
Mercè Boada, MD, PhD
Neuróloga. MD, PhD
Dirección de correo verificada de fundacioace.com
TítuloCitado porAño
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452, 2013
20222013
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo, S Gilman, JF Dartigues, B Laurent, M Puel, LC Kirby, ...
Neurology 61 (1), 46-54, 2003
15112003
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman, M Koller, RS Black, L Jenkins, SG Griffith, NC Fox, L Eisner, ...
Neurology 64 (9), 1553-1562, 2005
13232005
Genome-wide analysis of genetic loci associated with Alzheimer disease
S Seshadri, AL Fitzpatrick, MA Ikram, AL DeStefano, V Gudnason, ...
Jama 303 (18), 1832-1840, 2010
10602010
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox, RS Black, S Gilman, MN Rossor, SG Griffith, L Jenkins, M Koller
Neurology 64 (9), 1563-1572, 2005
5442005
Analysis of shared heritability in common disorders of the brain
V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ...
Science 360 (6395), eaap8757, 2018
3512018
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
2712001
A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer’s disease
L Tárraga, M Boada, G Modinos, A Espinosa, S Diego, A Morera, ...
Journal of Neurology, Neurosurgery & Psychiatry 77 (10), 1116-1121, 2006
2572006
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373, 2017
2562017
Trial of solanezumab for mild dementia due to Alzheimer’s disease
LS Honig, B Vellas, M Woodward, M Boada, R Bullock, M Borrie, K Hager, ...
New England Journal of Medicine 378 (4), 321-330, 2018
2152018
A phase II trial of tideglusib in Alzheimer's disease
S Lovestone, M Boada, B Dubois, M Hüll, JO Rinne, HJ Huppertz, ...
Journal of Alzheimer's Disease 45 (1), 75-88, 2015
1772015
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ...
Neurobiology of aging 31 (5), 725-731, 2010
1732010
Frontotemporal dementia and its subtypes: a genome-wide association study
R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ...
The Lancet Neurology 13 (7), 686-699, 2014
1692014
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ...
Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015
1652015
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
1452014
A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved
A Espinosa, M Alegret, S Valero, G Vinyes-Junqué, I Hernández, ...
Journal of Alzheimer's Disease 34 (3), 769-780, 2013
1202013
A novel Alzheimer disease locus located near the gene encoding tau protein
G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ...
Molecular psychiatry 21 (1), 108, 2016
1192016
Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis
SC Neu, J Pa, W Kukull, D Beekly, A Kuzma, P Gangadharan, LS Wang, ...
JAMA neurology 74 (10), 1178-1189, 2017
1082017
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
R Vandenberghe, JO Rinne, M Boada, S Katayama, P Scheltens, B Vellas, ...
Alzheimer's research & therapy 8 (1), 18, 2016
962016
Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease
M Balasa, E Gelpi, A Antonell, MJ Rey, R Sanchez-Valle, JL Molinuevo, ...
Neurology 76 (20), 1720-1725, 2011
912011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20